Potassium iodide for thyroid blockade in a reactor accident: Administrative policies that govern its use

Thyroid

Volumn 7, Issue 2, 1997, Pages 193-197

  Becker, David V ^a   Zanzonico, Pat ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM IODIDE;

CANCER RISK; CHERNOBYL ACCIDENT; FALLOUT; HUMAN; NUCLEAR ACCIDENT; NUCLEAR REACTOR; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; REVIEW; THYROID CANCER;

EID: 0030931202     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.193     Document Type: Review

References (15)

1. Royal HD 1990 Special aspects of nuclear power. In: Mettler FA (ed) Medical management of radiation accidents. CRC Press, Boca Raton, Florida, pp. 232-292.
2. Mettler FA, Becker DV, Wachholz B, et al. 1996 Chernobyl: 10 years later. J Nuc Med 37:24-27.
3. Becker DV, Robbins J, Beebe GW, et al. 1996 Childhood thyroid cancer following the Chernobyl accident. A status report. Endocrinol Metab Clin North Am 25:197-211
4. Becker DV 1987 Reactor accidents: Public health strategies and their medical implications. JAMA 258:649-654.
5. Becker DV 1983 Physiological basis for the use of potassium iodide as a thyroid blocking agent. Logistic issues in its distribution. In: Symposium on the Health Aspects of Nuclear Power Plant Incidents. Bull NY Acad Med 59:1003-1008.
6. Mettler FA, Royal HD, Hurley JR, et al. 1992 Administration of stable iodine to the population around the Chernobyl nuclear power plant. J Radiol Prot 12:159-165.
7. Yalow RS 1983 Risks in mass distribution of potassium iodide. In: Symposium on the Health Aspects of Nuclear Power Plant Incidents, Bull NY Acad Med 59:1020-1027.
8. Shleien B, Halpern JA, Bilstad JM, et al. 1983 Recommendations on the use of potassium iodide as a thyroidal-blocking agent in radiation accidents. An FDA update. In: Symposium on the Health Aspects of Nuclear Power Plant Incidents. Bull NY Acad Med 59:1009-1019.
9. Reactor Safety Study 1975 An assessment of accident risks in U.S. commercial nuclear power plants. WASH-1400. US Nuclear Regulatory Commission, Washington, DC.
10. National Council on Radiation Protection and Measurements 1977 Protection of the thyroid gland in the event of releases of radioiodine. NCRP Report no. 55 NCRP, Bethesda, Maryland.
11. Kemeny, JG 1979 Report of the President's Commission on the Accident at Three Mile Island. Washington, DC.
12. Guidelines for iodine prophylaxis following nuclear accidents. 1989 Environmental Health Series WHO, Copenhagen.
13. Petition to NRC for rule making 1995 Federal Register, 60, #227, Docket PRM 50-63.
14. Nauman J, Wolff J 1993 Iodide prophylaxis in Poland after the Chernobyl reactor accident: Benefits and risks. Am J Med 94:524-532.
15. Wolff J 1996 Iodide prophylaxis for reactor accidents. In: Nagataki S, Yamashita S (eds) Nagasaki Symposium Radiation and Human Health. Elsevier, Amsterdam, pp. 227-237.